Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30780
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKrishnadas, Natasha-
dc.contributor.authorDoré, Vincent-
dc.contributor.authorLaws, Simon M-
dc.contributor.authorPorter, Tenielle-
dc.contributor.authorLamb, Fiona-
dc.contributor.authorBozinovski, Svetlana-
dc.contributor.authorVillemagne, Victor L-
dc.contributor.authorRowe, Christopher C-
dc.date2022-
dc.date.accessioned2022-09-06T06:46:56Z-
dc.date.available2022-09-06T06:46:56Z-
dc.date.issued2022-
dc.identifier.citationAlzheimer's & Dementia (Amsterdam, Netherlands) 2022; 14(1): e12326en
dc.identifier.issn2352-8729
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30780-
dc.description.abstractNeocortical 3R4R (3-repeat/4-repeat) tau aggregates are rarely observed in the absence of amyloid beta (Aβ). 18F-MK6240 binds specifically to the 3R4R form of tau that is characteristic of Alzheimer's disease (AD). We report four cases with negative Aβ, but positive tau positron emission tomography (PET) findings. All Australian Imaging, Biomarkers and Lifestyle study of aging (AIBL) study participants with Aβ (18F-NAV4694) and tau (18F-MK6240) PET scans were included. Centiloid <25 defined negative Aβ PET (Aβ-). The presence of neocortical tau was defined quantitatively and visually. Aβ- PET was observed in 276 participants. Four of these participants (one cognitively unimpaired [CU], two mild cognitive impairment [MCI], one AD) had tau tracer retention in a pattern consistent with Braak tau stages V to VI. Fluid biomarkers supported a diagnosis of AD. In silico analysis of APP, PSEN1, PSEN2, and MAPT genes did not identify relevant functional mutations. Discordant cases were infrequent (1.4% of all Aβ- participants). In these cases, the Aβ PET ligand may not be detecting the Aβ that is present.en
dc.language.isoeng
dc.subjectAlzheimer's diseaseen
dc.subjectamyloid beta (Aβ)en
dc.subjectdiscordanten
dc.subjectpositron emission tomographyen
dc.subjecttauen
dc.titleExploring discordant low amyloid beta and high neocortical tau positron emission tomography cases.en
dc.typeJournal Articleen
dc.identifier.journaltitleAlzheimer's & Dementia (Amsterdam, Netherlands)en
dc.identifier.affiliationCollaborative Genomics and Translation Group School of Medical and Health Sciences Edith Cowan University Perth WA Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.affiliationHealth and Biosecurity Flagship The Australian eHealth Research Centre Melbourne Victoria Australiaen
dc.identifier.affiliationDepartment of Molecular Imaging & Therapy Austin Health Heidelberg Victoria Australiaen
dc.identifier.affiliationCentre for Precision Health Edith Cowan University Perth WA Australiaen
dc.identifier.affiliationDepartment of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA..en
dc.identifier.doi10.1002/dad2.12326en
dc.type.contentTexten
dc.identifier.orcidhttps://orcid.org/0000-0002-5374-2839en
dc.identifier.pubmedid36051174
local.name.researcherBozinovski, Svetlana
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptMolecular Imaging and Therapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

32
checked on Feb 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.